People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently ...

Once-weekly insulin efsitora alpha (efsitora) is noninferior to once-daily insulin glargine (glargine) for reducing glycated ...

The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott ...

Diabetes affects many people in the world, type 1 diabetes being a condition that can affect anyone, causing them to be on ...

Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, gathered with ...

Women with diabetes who were overweight or had obesity lost more weight and had greater odds of diabetes remission when ...

VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...

For high-risk patients with type 2 diabetes, oral semaglutide reduced risk for major cardiovascular and ischemic limb-related ...

Want to lose weight and reverse type 2 diabetes? Trade diet soda for a tall glass of water, a new small-scale study argues.

All 3 doses of orforglipron superior to placebo with respect to primary end point of change in HbA1c from baseline to week 40.